MET and cancer: Forced expression of MET in primary osteoblasts induces transformation and is essential for the maintenance of the cancer phenotype [157], while loss-of-function approaches in OS cell lines (143B and U2OS) demonstrated that this oncogene promotes cell proliferation, migration and invasion, and inhibits cell apoptosis [158].